-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BYtdpMPUerso2GJUrmi3zW3x7kVOKfBORrLlI04YCr9urymueoG3OlwKTH+WPH4J rOmhjuLHiKI4pNHywDLiMw== 0001072613-00-000140.txt : 20000214 0001072613-00-000140.hdr.sgml : 20000214 ACCESSION NUMBER: 0001072613-00-000140 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20000211 GROUP MEMBERS: ARTHUR J. MARKS GROUP MEMBERS: C. RICHARD KRAMLICH GROUP MEMBERS: CHARLES W. NEWHALL III GROUP MEMBERS: JOHN M. NEHRA GROUP MEMBERS: NANCY L. DORMAN GROUP MEMBERS: NEA PARTNERS VI, LIMITED PARTNERSHIP GROUP MEMBERS: NEW ENTERPRISE ASSOCIATES VI L P GROUP MEMBERS: NEW ENTERPRISE ASSOCIATES VI, LIMITED PARTNERSHIP GROUP MEMBERS: PETER J. BARRIS GROUP MEMBERS: RONALD KASE GROUP MEMBERS: THOMAS C. MCCONNELL SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MICROCIDE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001010915 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943186021 STATE OF INCORPORATION: CA FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-47911 FILM NUMBER: 534091 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 4154281550 MAIL ADDRESS: STREET 1: 850 MAUDE AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NEW ENTERPRISE ASSOCIATES VI L P CENTRAL INDEX KEY: 0000928154 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 521827316 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1119 ST PAUL ST CITY: BALTIMORE STATE: MD ZIP: 21202 MAIL ADDRESS: STREET 1: 1119 ST PAUL ST CITY: BALTIMORE STATE: MD ZIP: 21202 SC 13G/A 1 AMENDMENT NO. 2 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2)* Microcide Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 595018102 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 1999 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ITEM 1(A). NAME OF ISSUER: Microcide Pharmaceuticals, Inc. ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 850 Maude Avenue, Mountain View, CA 94043 ITEM 2(A). NAMES OF PERSONS FILING: New Enterprise Associates VI, Limited Partnership ("NEA VI"), NEA Partners VI, Limited Partnership ("NEA Partners VI"), which is the sole general partner of NEA VI, and Peter J. Barris ("Barris"), Nancy L. Dorman ("Dorman"), Ronald Kase ("Kase"), C. Richard Kramlich ("Kramlich"), Arthur J. Marks ("Marks"), Thomas C. McConnell ("McConnell"), John M. Nehra ("Nehra") and Charles W. Newhall III ("Newhall") (collectively the "General Partners"). The General Partners are individual general partners of NEA Partners VI. The persons named in this paragraph are referred to individually herein as a "Reporting Person" and collectively as the "Reporting Persons." ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: The address of the principal business office of NEA VI, NEA Partners VI, Bonsal, Dorman, Marks, Nehra and Newhall is New Enterprise Associates, 1119 St. Paul Street, Baltimore, Maryland 21202. The address of the principal business office of Kase, Kramlich and McConnell is New Enterprise Associates, 2490 Sand Hill Road, Menlo Park, California 94025. The address of the principal business office of Barris is New Enterprise Associates, 11911 Freedom Drive, One Fountain Square, Suite 580, Reston, Virginia 20190. ITEM 4. OWNERSHIP. Not applicable. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Each Reporting Person has ceased to own beneficially more than 5% of the outstanding Common Stock of Microcide Pharmaceuticals, Inc. ALL OTHER ITEMS REPORTED ON THE SCHEDULE 13G DATED AS OF FEBRUARY 1997 ON BEHALF OF THE REPORTING PERSONS WITH RESPECT TO THE COMMON STOCK OF MICROCIDE PHARMACEUTICALS, INC. REMAIN UNCHANGED. SIGNATURE --------- After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: January 25, 2000 NEW ENTERPRISE ASSOCIATES VI, LIMITED PARTNERSHIP By: NEA PARTNERS VI, LIMITED PARTNERSHIP By: * ----------------------------- Charles W. Newhall III General Partner NEA PARTNERS VI, LIMITED PARTNERSHIP By: * ---------------------------- Charles W. Newhall III General Partner * - --------------------------------- Peter J. Barris * - --------------------------------- Ronald Kase * - --------------------------------- C. Richard Kramlich * - --------------------------------- Arthur J. Marks * - --------------------------------- Thomas C. McConnell * - --------------------------------- John M. Nehra * - --------------------------------- Charles W. Newhall III By: /s/ Nancy L. Dorman ---------------------------------- Nancy L. Dorman, in her individual capacity and as Attorney-in-Fact - -------------------------------------------------------------------------------- This Schedule 13G was executed by Nancy L. Dorman pursuant to Powers of Attorney filed with the Securities and Exchange Commission on February 13, 1992 in connection with a Schedule 13G for Advanced Interventional Systems Inc. and on February 13, 1995 in connection with a Schedule 13G for Acuity Imaging, Inc., which Powers of Attorney are incorporated herein by reference and copies of which are attached hereto as Exhibit 1. EX-99.1 2 POWER OF ATTORNEY EXHIBIT 1 --------- POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Nancy L. Dorman and Charles W. Newhall III, and each of them, with full power to act without the other, his true and lawful attorney-in-fact, with full power of substitution, to sign any and all instruments, certificates and documents that may be necessary, desirable or appropriate to be executed on behalf of himself as an individual or in his capacity as a general partner of any partnership, pursuant to section 13 or 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any and all regulations promulgated thereunder, and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and with any other entity when and if such is mandated by the Exchange Act or by the By-laws of the National Association of Securities Dealers, Inc., granting unto said attorney-in-fact full power and authority to do and perform each and every act and thing necessary, desirable or appropriate, fully to all intents and purposes as he might or could do in person, thereby ratifying and confirming all that said attorney-in-fact, or his substitutes, may lawfully do or cause to be done by virtue hereof. IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 23rd day of April, 1991. /s/ Raymond L. Bank --------------------------- Raymond L. Bank /s/ Thomas R. Baruch --------------------------- Thomas R. Baruch /s/ Cornelius C. Bond, Jr. --------------------------- Cornelius C. Bond, Jr. /s/ Frank A. Bonsal, Jr. --------------------------- Frank A. Bonsal, Jr. /s/ James A. Cole --------------------------- James A. Cole /s/ Nancy L. Dorman --------------------------- Nancy L. Dorman /s/ Neal M. Douglas --------------------------- Neal M. Douglas /s/ John W. Glynn, Jr. --------------------------- John W. Glynn, Jr. /s/ Curran W. Harvey --------------------------- Curran W. Harvey /s/ Ronald Kase --------------------------- Ronald Kase /s/ C. Richard Kramlich --------------------------- C. Richard Kramlich /s/ Robert F. Kuhling --------------------------- Robert F. Kuhling /s/ Arthur J. Marks --------------------------- Arthur J. Marks /s/ Thomas C. McConnell --------------------------- Thomas C. McConnell /s/ Donald L. Murfin --------------------------- Donald L. Murfin /s/ H. Leland Murphy --------------------------- H. Leland Murphy /s/ John M. Nehra --------------------------- John M. Nehra /s/ Charles W. Newhall III --------------------------- Charles W. Newhall III /s/ Terry L. Opdendyk --------------------------- Terry L. Opdendyk /s/ Barbara J. Perrier --------------------------- Barbara J. Perrier /s/ C. Vincent Prothro --------------------------- C. Vincent Prothro /s/ C. Woodrow Rea, Jr. --------------------------- C. Woodrow Rea, Jr. /s/ Howard D. Wolfe, Jr. --------------------------- Howard D. Wolfe, Jr. /s/ Nora M. Zietz --------------------------- Nora M. Zietz POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Nancy L. Dorman and Charles W. Newhall III, and each of them, with full power to act without the other, his true and lawful attorney-in-fact, with full power of substitution, to sign any and all instruments, certificates and documents that may be necessary, desirable or appropriate to be executed on behalf of himself as an individual or in his capacity as a general partner of any partnership, pursuant to section 13 or 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any and all regulations promulgated thereunder, and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and with any other entity when and if such is mandated by the Exchange Act or by the By-laws of the National Association of Securities Dealers, Inc., granting unto said attorney-in-fact full power and authority to do and perform each and every act and thing necessary, desirable or appropriate, fully to all intents and purposes as he might or could do in person, thereby ratifying and confirming all that said attorney-in-fact, or his substitutes, may lawfully do or cause to be done by virtue hereof. IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 1st day of January, 1994. /s/ Peter J. Barris --------------------------- Peter J. Barris /s/ Debra E. King --------------------------- Debra E. King /s/ Peter T. Morris --------------------------- Peter. T. Morris /s/ Hugh Y. Rienhoff, Jr. --------------------------- Hugh Y. Rienhoff, Jr. /s/ Alexander Slusky --------------------------- Alexander Slusky /s/ Louis B. Van Dyck --------------------------- Louis B. Van Dyck -----END PRIVACY-ENHANCED MESSAGE-----